Brief: Cassava Sciences Q3 Basic EPS USD -0.22

Filana Therapeutics

12/11/2025 13:00

Nov 12 (Reuters) - Cassava Sciences Q3 operating expenses USD 11.86 million.

Q3 net income USD -10.807 million

Q3 EPS USD -0.22

Q3 operating income USD -11.86 million